TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/26/2026
Back to search
Official data from USPTO
SENTRY BIOPHARMA SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079312619Class
35, 39, 42, 45
Filing
79312619
Registration
7301311
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
02/28/2026
Trademark type
Combined
Nice classes
35, 39, 42, 45
Filing date
12/01/2020
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
US
Examiner
MAHONEY, PAULA M
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized gray wording "SENTRY BIOPHARMA SERVICES" with "BIOPHARMA SERVICES" appearing under the "NTRY" of "SENTRY". To the left of the wording is a stylized yellow design comprised of five large circles, arranged horizontally with a line extending upward to a smaller circle from the right side of the top circle, as well as a line and circle design extending downward from the right side of the third circle and a line and circle design extending leftward from the left side of the fourth circle.
Holders and representatives
Holders
Sentry BioPharrna Services, Inc.
Representatives
Kiranjit K Dharsan Seiter IP
Technical classification
Nice Classes
Class 35Class 39Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing business and statistical information and data processing services in the pharmaceuticalbiotechnologymedical devicediagnostics industries; compilationupdating and maintenance of information into computer databases; government relations consultancy services regarding customs clearance for third parties; business administration servicescustoms clearance services for third parties
Class 39
Supply chain logistics and storage of temperature sensitive healthcare products for the pharmaceuticalbiotechnology and medical device industries in a climate-controlled environment
Class 42
Providing a web hosting platform for supply chain logistics and freight forwarding services; providing transportation information; electronic data storage services; computer servicesupdating of computer programs
Class 45
Advice and regulatory compliance consulting in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesdiagnostics
Publications
History of USPTO decisions and trademark events.
39 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/26/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/26/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/26/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/26/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/02/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/14/2024
FIMP
FINAL DISPOSITION PROCESSED
05/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/26/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/26/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/05/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/01/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/01/2022
CNSL
SUSPENSION LETTER WRITTEN
09/01/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/28/2021
RFNT
REFUSAL PROCESSED BY IB
08/29/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/06/2021
RFRR
REFUSAL PROCESSED BY MPU
08/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/28/2021
CNRT
NON-FINAL ACTION WRITTEN
07/27/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2021
DOCK
ASSIGNED TO EXAMINER
06/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2021
Continuous trademark protection
Get notified about every new filing that threatens SENTRY BIOPHARMA SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.